Evidence map›Paper›PMID 41680400›Full record

ArticleJournal of computer-aided molecular design2026

Multi-spatial channel attention and inceptionv3-based CAD system with optimized MLP for lung cancer detection.

Marjan Pahlevani, Sasipriya Vejendla, Sonya Hsu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marjan PahlevaniSchool of Computing and Informatics, University of Louisiana at Lafayette, Lafayette, USA. marjan.pahlevani1@louisiana.edu.
Sasipriya VejendlaSchool of Computing and Informatics, University of Louisiana at Lafayette, Lafayette, USA.
Sonya HsuAssociate professor, School of Computing and Informatics, University of Louisiana at Lafayette, Lafayette, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains one of the deadliest cancers worldwide, largely due to late-stage diagnosis and the complex, often asymptomatic progression of the disease. The study presents a new noise-aware Computer-Aided Diagnosis (CAD) framework for lung cancer detection in CT scans, addressing the critical challenge of image noise that can obscure vital diagnostic details. Thus, the proposed work uses a multilayer perceptron-based classifier that uses texture descriptors from the Gray Level Co-Occurrence Matrix (GLCM) and Local Binary Pattern (LBP), integrates Inception V3 for feature extraction, and introduces a high-level adaptive Gaussian filter with Multi-spatial Channel Attention (MSCA) convolutional segmentation. Finally, classification was achieved via a multilayer perceptron (MLP) using a novel Adaptive Osprey Optimization Algorithm (AOOA). This architecture enables effective feature learning, segmentation, and classification through modular integration of CNN, attention, and statistical texture extraction. The experimental results on the IQ-OTH/NCCD dataset show a classification accuracy (0.9894), specificity (0.9917), sensitivity (0.9846), and AUC metrics. This framework holds strong potential for real-world clinical integration, offering improved early diagnosis and supporting radiologists in lung cancer assessment.

Indexed as

Diagnosis, Computer-AssistedLung NeoplasmsAlgorithmsClassification AlgorithmsConvolutional Neural NetworksHumansMultilayer PerceptronsTomography, X-Ray ComputedComputed tomographyComputer-aided diagnosisGray level co-occurrence matrixLocal binary patternLung cancer detectionMultilayer perceptionOsprey optimization algorithm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.